Edition:
United States

People: Forward Pharma A/S (FWP.OQ)

FWP.OQ on NASDAQ Stock Exchange Global Select Market

1.18USD
25 Apr 2019
Change (% chg)

-- (--)
Prev Close
$1.18
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,039
52-wk High
$4.42
52-wk Low
$0.71

Svendsen, Claus 

Mr. Claus Bo Svendsen, M.D. Ph.D., has served as Chief Executive Officer of Forward Pharma A/S since March 1, 2017. He previously held the position of Executive Vice President at the Company. Mr. Svendsen joined the Company in 2015, prior to which he held positions of increasing seniority in the Danish pharmaceutical company, Novo Nordisk A/S, with his last role being Global Medical Director. Previously, Mr. Svendsen worked in biotech venture capital and has a clinical background in internal medicine. He graduated as a Medical Doctor from University of Copenhagen in 2003, and additionally completed a Ph.D. in sarcoidosis pathobiology in 2009.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --